Axogen (AXGN) Cash from Investing Activities (2010 - 2026)
Axogen (AXGN) posted quarterly Cash from Investing Activities of $500000.0 for Q2 2026, up 107.2% year-over-year from $241315.8 in Q2 2025, and up 103.13% quarter-over-quarter from -$16.0 million in Q1 2026.
Axogen (AXGN) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Axogen's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $500000.0 for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 107.2% year-over-year to $500000.0; the TTM figure through Jun 2026 stood at -$15.2 million (down 32.85% YoY), while the FY2025 annual figure was -$5.3 million, up 48.36% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at $500000.0, up from -$16.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $14.3 million in Q2 2023, with the low at -$16.0 million in Q1 2026.
- The 5-year median for Cash from Investing Activities is -$799500.0 (2023), against an average of -$834722.2.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities soared 597.17% in 2025, then plunged 1292.23% in 2026.
- Axogen's Cash from Investing Activities stood at -$1.2 million in 2022, then soared by 77.09% to -$277000.0 in 2023, then plunged by 193.5% to -$813000.0 in 2024, then jumped by 597.17% to $4.0 million in 2025, then plunged by 87.63% to $500000.0 in 2026.
- Business Quant data shows AXGN's Cash from Investing Activities at $500000.0 in Q2 2026, -$16.0 million in Q1 2026, and $4.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Axogen | 2.43 Bn | 2.32 Bn | 50.67 Mn | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Jun 30, 2026 | 500,000.00 |
| Mar 31, 2026 | -15.96 Mn |
| Mar 31, 2026 | -15.96 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | -3.75 Mn |
| Sep 30, 2025 | -3.75 Mn |
| Jun 30, 2025 | -6.95 Mn |
| Jun 30, 2025 | -6.95 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | -813,000.00 |
| Dec 31, 2024 | -813,000.00 |
| Sep 30, 2024 | -5.00 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Mar 31, 2024 | -3.25 Mn |